Tc-99m pyrophosphate left atrial uptake in patients with atrial fibrillation and cardiac amyloidosis

Affiliations

¹ Division of Nuclear Medicine, London Health Sciences Centre, University Hospital, 339 Windermere Road, PO Box 5010, London, ON, N6A 5A5, Canada. ramiabazid@yahoo.com.
² Division of Nuclear Medicine, London Health Sciences Centre, University Hospital, 339 Windermere Road, PO Box 5010, London, ON, N6A 5A5, Canada.
³ Division of Cardiology, London Health Sciences Centre, University Hospital, 339 Windermere Road, PO Box 5010, London, ON, N6A 5A5, Canada.

Rami M Abazid et al. J Nucl Cardiol. 2022 Oct.

. 2022 Oct;29(5):2731-2733.

doi: 10.1007/s12350-020-02508-3. Epub 2021 Jan 27.

¹ Division of Nuclear Medicine, London Health Sciences Centre, University Hospital, 339 Windermere Road, PO Box 5010, London, ON, N6A 5A5, Canada. ramiabazid@yahoo.com.
² Division of Nuclear Medicine, London Health Sciences Centre, University Hospital, 339 Windermere Road, PO Box 5010, London, ON, N6A 5A5, Canada.
³ Division of Cardiology, London Health Sciences Centre, University Hospital, 339 Windermere Road, PO Box 5010, London, ON, N6A 5A5, Canada.

No abstract available

References

1. Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA et al. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging. J Nucl Cardiol 2019;26:2065-123. https://doi.org/10.1007/s12350-019-01760-6 . - DOI - PubMed
1. Longhi S, Quarta CC, Milandri A, Lorenzini M, Gagliardi C, Manuzzi L et al. Atrial fibrillation in amyloidotic cardiomyopathy: prevalence, incidence, risk factors and prognostic role. Amyloid 2015;22:147-55. https://doi.org/10.3109/13506129.2015.1028616 . - DOI - PubMed